These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24664584)

  • 1. NEDD9 overexpression correlates with poor prognosis in gastric cancer.
    Liu Y; Wang D; Zhao KL; Zhu JW; Yin HB; Wei YZ; Wu ZJ; Cheng GJ; Wang F; Ni F; Wang XL; Cao GX; Huang J; Cai J
    Tumour Biol; 2014 Jul; 35(7):6351-6. PubMed ID: 24664584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
    Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
    Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Nedd9 is a prognostic marker of human gastric cancer.
    Zhang Q; Wang H; Ma Y; Zhang J; He X; Ma J; Zhao ZS
    Med Oncol; 2014 Jul; 31(7):33. PubMed ID: 24906654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.
    Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH
    Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of NEDD9 in the invasion and migration of gastric cancer.
    Feng J; Zhao J; Xie H; Yin Y; Luo G; Zhang J; Feng Y; Li Z
    Tumour Biol; 2015 May; 36(5):3621-8. PubMed ID: 25577245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTSS1 overexpression correlates with poor prognosis in colorectal cancer.
    Wang D; Xu MR; Wang T; Li T; Zhu Jw
    J Gastrointest Surg; 2011 Jul; 15(7):1205-12. PubMed ID: 21562916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of NEDD9 and connexin-43 in neoplastic and stromal cells of gastric adenocarcinoma.
    Lerotić I; Vuković P; Hrabar D; Misir Z; Kruljac I; Pavić T; Forgač J; Ćaćić P; Ulamec M
    Bosn J Basic Med Sci; 2021 Oct; 21(5):542-548. PubMed ID: 33485292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of NEDD9 in hepatocellular carcinoma and its clinical significance.
    Lu P; Wang ZP; Dang Z; Zheng ZG; Li X; Zhou L; Ding R; Yue SQ; Dou KF
    Oncol Rep; 2015 May; 33(5):2375-83. PubMed ID: 25812772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
    Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
    Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression.
    Pang L; Wang J; Fan Y; Xu R; Bai Y; Bai L
    Cancer Biomark; 2018; 23(1):53-59. PubMed ID: 30010108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance.
    Xue YZ; Sheng YY; Liu ZL; Wei ZQ; Cao HY; Wu YM; Lu YF; Yu LH; Li JP; Li ZS
    Tumour Biol; 2013 Apr; 34(2):895-9. PubMed ID: 23247867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma.
    Liu G; Peng X; Cai Y; Cheng A; Zha L; Wang Z
    Hum Pathol; 2017 Dec; 70():35-42. PubMed ID: 28601661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
    Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
    Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of NEDD9 predicts adverse outcomes of colorectal cancer patients.
    Li P; Zhou H; Zhu X; Ma G; Liu C; Lin B; Mao W
    Int J Clin Exp Pathol; 2014; 7(5):2565-70. PubMed ID: 24966970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of NEDD9, E-cadherin and γ-catenin and their prognostic significance in pancreatic ductal adenocarcinoma (PDAC).
    Radulović P; Krušlin B
    Bosn J Basic Med Sci; 2018 Aug; 18(3):246-251. PubMed ID: 29924959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTO expression is associated with the occurrence of gastric cancer and prognosis.
    Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X
    Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
    Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
    Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.
    Hong SA; Son MW; Cho J; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee MS
    APMIS; 2017 Nov; 125(11):996-1006. PubMed ID: 28885730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.